Trial Profile
Excretion and metabolism of [14C]aclidinium bromide administered intravenously in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2022
Price :
$35
*
At a glance
- Drugs Aclidinium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Almirall S.A.; Covance; Forest
- 05 Nov 2010 New trial record.